Eloxx Pharmaceuticals, Inc.

ELOX - Company ID 0001035354

Market cap-

Rank-

Filings1,006

Eloxx Pharmaceuticals, Inc. has filed 1,006 public company documents between 2008 and 2026. The most frequent type is insider trade (409 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchELOX overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut ELOX beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ELOX via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

BIIBBiogen Inc.

BNTXBioNTech SE

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-06-17	-	View filing
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-06-17	-	View filing
4	Insider trade	1mo ago2026-06-17	2026-06-10	View filing
3	New insider ownership	1mo ago2026-06-17	2026-06-05	View filing
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-06-16	-	View filing
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-06-16	-	View filing
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-06-15	-	View filing
4	Insider trade	1mo ago2026-06-10	2026-06-08	View filing
4	Insider trade	1mo ago2026-06-10	2026-06-08	View filing
4	Insider trade	1mo ago2026-06-10	2026-06-10	View filing
4	Insider trade	1mo ago2026-06-10	2026-06-08	View filing
4	Insider trade	1mo ago2026-06-10	2026-06-08	View filing
424B4	424B4	1mo ago2026-06-09	-	View filing
EFFECT	EFFECT	1mo ago2026-06-08	-	View filing
CERT	Exchange certification	1mo ago2026-06-08	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1mo ago2026-06-05	-	View filing
4	Insider trade	1mo ago2026-06-05	2026-05-27	View filing
S-1/A	S-1/A	1mo ago2026-06-04	-	View filing
8-A12B	8-A12B	1mo ago2026-06-01	-	View filing
S-1/A	S-1/A	1mo ago2026-06-01	-	View filing
8-K	Major company event	1mo ago2026-06-01	2026-05-27	View filing
3	New insider ownership	1mo ago2026-06-01	2026-05-27	View filing
3	New insider ownership	1mo ago2026-06-01	2026-05-27	View filing
4	Insider trade	1mo ago2026-05-29	2026-05-27	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1mo ago2026-05-29	-	View filing
4	Insider trade	2mo ago2026-05-08	2025-09-19	View filing
4	Insider trade	2mo ago2026-05-08	2022-02-06	View filing
4	Insider trade	2mo ago2026-05-08	2025-09-19	View filing
DEF 14C	DEF 14C	2mo ago2026-05-08	2026-05-08	View filing
S-1	IPO registration	2mo ago2026-05-07	-	View filing
10-Q	Quarterly report	2mo ago2026-05-05	2026-03-31	View filing
3	New insider ownership	2mo ago2026-05-04	2026-04-28	View filing
SCHEDULE 13G	SCHEDULE 13G	2mo ago2026-05-04	-	View filing
8-K	Major company event	2mo ago2026-05-01	2026-04-28	View filing
SCHEDULE 13G	SCHEDULE 13G	2mo ago2026-05-01	-	View filing
3	New insider ownership	2mo ago2026-05-01	2026-04-27	View filing
PRE 14C	PRE 14C	2mo ago2026-04-28	2026-04-28	View filing
DRS	DRS	4mo ago2026-03-20	-	View filing
10-K	Annual report	4mo ago2026-03-17	2025-12-31	View filing

Eloxx Pharmaceuticals, Inc.

Similar companies to research next

Year